Found 17 matching trials
"A Long-Term Safety Study of JZP-110 in the Treatment of Excessive Sleepiness in Subjects With Narcolepsy or OSA" PHASE3 This is a Phase 3 study to assess the long-term safety and maintenance of e...
Show More Location
Sleep Disorders Center of Alabama
Learn More & Join Trial
Solriamfetol and CBT-I in Patients With Insomnia Disorder PHASE4 Medication is FDA approved. The objective of this project is to test the ef...
Show More Location
University of Pennsylvania, Behavioral Sleep Medicine Program
Learn More & Join Trial
Solriamfetol in Binge Eating Disorder PHASE4 The goal of this project is to evaluate the efficacy and tolerability of th...
Show More Location
Lindner Center of HOPE
Learn More & Join Trial
"Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA" PHASE3 This trial is a 12 week, randomized, double-blind, placebo controlled, mult...
Show More Location
Pulmonary Associates
Learn More & Join Trial
Efficacy and Tolerance of Solriamfetol in Patients Affected with Idiopathic Hypersomnia. PHASE2 This Phase II clinical trial is a monocenter, double-blind, randomized, pla...
Show More Location
University Hospital of Montpellier
Learn More & Join Trial
"Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in Narcolepsy" PHASE3 This trial is a 12-week, randomized, double-blind, placebo controlled, mult...
Show More Location
Sleep Disorders Center of Alabama
Learn More & Join Trial
RECOVER-SLEEP: Platform Protocol PHASE2 The platform protocol is designed to be flexible so that it is suitable for...
Show More Location
Banner University Medical Center Phoenix
Learn More & Join Trial
RECOVER-SLEEP: Platform Protocol, Appendix_A (Hypersomnia) PHASE2 The platform protocol is designed to be flexible so that it is suitable for...
Show More Location
All sites listed under NCT06404086
Learn More & Join Trial
A 4-Week Study of the Safety, Efficacy, and Pharmacokinetics of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in Subjects With Parkinson's Disease and Excessive Sleepiness PHASE2 This study is a 4-week, multicenter, randomized, double-blind, placebo-cont...
Show More Location
Southern California Institute For Respiratory Diseases, Inc.
Learn More & Join Trial
Solriamfetol's Effect on Cognitive Health in Apnea Participants During a Randomized Placebo-controlled Study PHASE4 The purpose of study JZP110-405 is to determine whether solriamfetol is eff...
Show More Location
Southern California Institute for Respiratory Disease
Learn More & Join Trial